no code implementations • 28 May 2024 • Dominic LaBella, Katherine Schumacher, Michael Mix, Kevin Leu, Shan McBurney-Lin, Pierre Nedelec, Javier Villanueva-Meyer, Jonathan Shapey, Tom Vercauteren, Kazumi Chia, Omar Al-Salihi, Justin Leu, Lia Halasz, Yury Velichko, Chunhao Wang, John Kirkpatrick, Scott Floyd, Zachary J. Reitman, Trey Mullikin, Ulas Bagci, Sean Sachdev, Jona A. Hattangadi-Gluth, Tyler Seibert, Nikdokht Farid, Connor Puett, Matthew W. Pease, Kevin Shiue, Syed Muhammad Anwar, Shahriar Faghani, Muhammad Ammar Haider, Pranav Warman, Jake Albrecht, András Jakab, Mana Moassefi, Verena Chung, Alejandro Aristizabal, Alexandros Karargyris, Hasan Kassem, Sarthak Pati, Micah Sheller, Christina Huang, Aaron Coley, Siddharth Ghanta, Alex Schneider, Conrad Sharp, Rachit Saluja, Florian Kofler, Philipp Lohmann, Phillipp Vollmuth, Louis Gagnon, Maruf Adewole, Hongwei Bran Li, Anahita Fathi Kazerooni, Nourel Hoda Tahon, Udunna Anazodo, Ahmed W. Moawad, Bjoern Menze, Marius George Linguraru, Mariam Aboian, Benedikt Wiestler, Ujjwal Baid, Gian-Marco Conte, Andreas M. Rauschecker, Ayman Nada, Aly H. Abayazeed, Raymond Huang, Maria Correia de Verdier, Jeffrey D. Rudie, Spyridon Bakas, Evan Calabrese
The 2024 Brain Tumor Segmentation Meningioma Radiotherapy (BraTS-MEN-RT) challenge aims to advance automated segmentation algorithms using the largest known multi-institutional dataset of radiotherapy planning brain MRIs with expert-annotated target labels for patients with intact or postoperative meningioma that underwent either conventional external beam radiotherapy or stereotactic radiosurgery.
no code implementations • 7 Aug 2020 • Dejan Kostyszyn, Tobias Fechter, Nico Bartl, Anca L. Grosu, Christian Gratzke, August Sigle, Michael Mix, Juri Ruf, Thomas F. Fassbender, Selina Kiefer, Alisa S. Bettermann, Nils H. Nicolay, Simon Spohn, Maria U. Kramer, Peter Bronsert, Hongqian Guo, Xuefeng Qiu, Feng Wang, Christoph Henkenberens, Rudolf A. Werner, Dimos Baltas, Philipp T. Meyer, Thorsten Derlin, Mengxia Chen, Constantinos Zamboglou
Accurate delineation of the intraprostatic gross tumour volume (GTV) is a prerequisite for treatment approaches in patients with primary prostate cancer (PCa).